Prenetics Global Ltd. (PRE)
16.77
+0.85
(+5.34%)
USD |
NASDAQ |
May 22, 16:00
16.64
-0.13
(-0.78%)
After-Hours: 20:00
Prenetics Global Shareholders Equity (Quarterly) : 156.46M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| GeneDx Holdings Corp. | 254.12M |
| Quest Diagnostics, Inc. | 7.366B |
| Labcorp Holdings, Inc. | 8.729B |
| Psychemedics Corp. | -- |
| Fulgent Genetics, Inc. | 1.050B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 206.07M |
| Total Liabilities (Quarterly) | 49.71M |
| Debt to Equity Ratio | 0.0113 |
| Current Ratio | 2.967 |
| Net Debt Paydown Yield | 0.36% |